Form 4: Exact Sciences GC Herriott Boosts Stake with RSU Grant

Sentiment:

Insider Transaction Report


Exact Sciences' SVP, General Counsel & Secretary, James Herriott, received a grant of 20,321 restricted stock units, increasing his beneficial ownership.

Summary

  • James Herriott, SVP, General Counsel & Secretary of Exact Sciences Corp (EXAS), reported changes in his beneficial ownership.
  • Acquired 20,321 Restricted Stock Units (RSUs) on February 25, 2026.
  • Each RSU represents a contingent right to receive one share of common stock.
  • These RSUs will vest in four equal annual installments, commencing on February 25, 2027.
  • Following this transaction, Mr. Herriott directly holds 67,815 shares of Common Stock and indirectly holds 1,762 shares in a 401(k) Plan, totaling 69,577 shares.
  • Additionally, Mr. Herriott holds an aggregate of 23,975 vested and unvested options to purchase shares of Common Stock and other restricted stock units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting continued insider alignment and confidence in Exact Sciences' long-term strategy through a standard executive compensation mechanism.

Positives

  • The grant of Restricted Stock Units aligns management's interests with long-term shareholder value, as the value of the units is tied to the company's stock performance.
  • Increased beneficial ownership by a key executive signals confidence in the company's future prospects.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that executive RSU grants are a common form of long-term incentive compensation in the biotechnology and diagnostics industry, designed to retain key talent and align executive performance with shareholder returns. This grant to a senior legal officer is a standard practice for public companies like Exact Sciences.

Stakeholder Impact

  • Shareholders: The RSU grant aligns the interests of a key executive with shareholders, as the value of the compensation is directly tied to the company's stock performance, potentially encouraging decisions that enhance shareholder value.

Next Steps

  • The Restricted Stock Units will vest in four equal annual installments beginning on February 25, 2027.

Key Dates

DateDescription
02/25/2026Date of transaction for the acquisition of Restricted Stock Units.
02/25/2027First vesting date for the acquired Restricted Stock Units, with subsequent installments annually thereafter.
02/27/2026Date the Form 4 was signed by James Herriott via attorney-in-fact.

Recommendation

hold

While the RSU grant indicates insider confidence and aligns executive interests with shareholders, a Form 4 filing primarily reports a compensation event rather than new operational or financial performance data. It provides a positive signal regarding management's long-term commitment but does not, on its own, present sufficient new information to warrant a change from a 'hold' position for a seasoned investor, who would typically consider broader financial and strategic factors.

Keywords

Exact Sciences, EXAS, James Herriott, Restricted Stock Units, RSU, Insider Transaction, Form 4, Executive Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.